Home PortfoliosNTSG 66.6:DBMFE 16.7:BTC 16.7

NTSG 66.6:DBMFE 16.7:BTC 16.7

Created byuser-knkh6q

Monthly Rebalancing

EUR

Moderate Risk

1.1yr backtest

Performance Summary

Total Return+13.30%

Annualized Return+12.02%

Volatility+14.69%

Sharpe Ratio0.68

Max Drawdown+10.95%

Holdings

Asset Allocation

Asset Class

Equity 83.3%Cryptocurrencies 16.7%

Holdings Details

This ETF portfolio offers global diversification with 83% equities, 17% cryptocurrencies for growth potential across developed markets, digital assets.

Asset	ISIN	Dist. Policy	Type	Allocation	TER
NTSG.XETRA WisdomTree Global Efficient Core UCITS ETF USD Unhedged Acc • IE00077IIPQ8	IE00077IIPQ8	Acc	ETF	66.6%	0.25%
DBMFE.PA iMGP DBi Managed Futures Fund R EUR ETF UCITS ETF • LU2951555403	LU2951555403	Acc	ETF	16.7%	0.75%
21BC.XETRA 21shares Bitcoin Core ETP • CH1199067674	CH1199067674	Acc	ETF	16.7%	0.1%
Total		Total			100.0%	0.31%

Performance

Portfolio Value Over Time

Starting with €10,000 investment → now worth €11,330.35

Histogram of Monthly Returns

The portfolio had a positive return during 6 of the 14 months (43%)

Monthly Returns Heatmap

Best month: +6.2% • Worst month: -3.2% • Best year: 2025 (+9.4%) • Worst year: 2026 (+3.5%)

Year	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Total
2026	-0.6%	-1.0%	-3.1%	+6.2%	+2.3%	-	-	-	-	-	-	-	+3.5%
2025	-	-	-	-2.5%	+5.6%	-0.4%	+5.4%	-2.2%	+3.0%	+5.2%	-3.2%	-1.2%	+9.4%

> +2%

0% to +2%

-2% to 0%

< -2%

Drawdown Analysis

Maximum drawdown: +10.95% • The longest drawdown period lasted for 6 months and was between November 2025 and May 2026. It reached a trough of -9.3%.

Detailed Metrics

Returns

Total Return

+13.30%

Annualized Return

+12.02%

Avg Monthly Return

+0.95%

Risk

Volatility (Annual)

+14.69%

Max Drawdown

+10.95%

Positive Months

43%

Average Drawdown

-3.3%

Risk-Adjusted

Sharpe Ratio

0.68

Risk-free rate: 2.0%

Sortino Ratio

0.64

Downside risk adjusted

Return/Volatility

0.82

Calmar Ratio

1.10

Return/Max Drawdown

Ulcer Index

3.87

Drawdown depth & duration

Martin Ratio

0.03

Return/Ulcer Index

Backtest Configuration

Initial Investment

€10,000

Final Value

€11,330.35

Backtest Period

2025-04-01 to 2026-05-08
1.1 years

Rebalancing

monthly

Base Currency

EUR